1. Zhou, Q., et al., Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report. Ann Palliat Med, 2020. 9(4): p. 2386-2392.
2. Blandin Knight, S., et al., Progress and prospects of early detection in lung cancer. Open Biol, 2017. 7(9).
3. Kumar, M., et al., Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy. Expert Opin Drug Deliv, 2020: p. 1-14.
4. You, L., et al., Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer. J Proteome Res, 2020. 19(9): p. 3750-3760.
5. Ma, F., et al., LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer. Front Genet, 2020. 11: p. 250.
6. Chen, L.M., et al., LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci, 2020. 24(9): p. 4810-4821.
7. Zhao, L., et al., Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p. Cancer Biother Radiopharm, 2020. 35(5): p. 362-370.
8. Yu, P.F., et al., LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer. Eur Rev Med Pharmacol Sci, 2019. 23(19): p. 8403-8410.
9. Cai, P., et al., MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1. Oncol Lett, 2020. 19(3): p. 1958-1966.
10. Moeng, S., et al., MicroRNA-107 Targets IKBKG and Sensitizes A549 Cells to Parthenolide. Anticancer Res, 2018. 38(11): p. 6309-6316.
11. Qian, B., et al., LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107. Eur Rev Med Pharmacol Sci, 2018. 22(18): p. 5946-5953.
12. Ke, S., et al., Long Noncoding RNA NEAT1 Aggravates Abeta-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease. Yonsei Med J, 2019. 60(7): p. 640-650.
13. Zhen, Y., et al., Knockdown of NEAT1 repressed the malignant progression of glioma through sponging miR-107 and inhibiting CDK14. J Cell Physiol, 2019. 234(7): p. 10671-10679.
14. Wang, P., et al., Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. J Exp Clin Cancer Res, 2016. 35: p. 22.
15. Gao, F. and J. Tian, FOXK1, Regulated by miR-365-3p, Promotes Cell Growth and EMT Indicates Unfavorable Prognosis in Breast Cancer. Onco Targets Ther, 2020. 13: p. 623-634.
16. Long, Z. and Y. Wang, miR-195-5p Suppresses Lung Cancer Cell Proliferation, Migration, and Invasion Via FOXK1. Technol Cancer Res Treat, 2020. 19: p. 1533033820922587.
17. Ma, X., et al., Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis. Biochem Biophys Res Commun, 2018. 498(4): p. 1009-1015.
18. Jing, H., et al., A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer. Med Sci Monit, 2018. 24: p. 4317-4323.
19. Yu, S., et al., Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer. Cancer Sci, 2019. 110(7): p. 2211-2225.
20. Sun, C., et al., Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget, 2016. 7(32): p. 51784-51814.
21. Hornick, N.I., et al., AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci Signal, 2016. 9(444): p. ra88.
22. Jiang, P., et al., NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Oncotarget, 2016. 7(28): p. 43337-43351.
23. Sun, W., et al., NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death Dis, 2018. 9(3): p. 380.
24. Koyama, S., et al., NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44. Int J Mol Sci, 2020. 21(6).
25. Xia, H., Y. Li, and X. Lv, MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int J Oncol, 2016. 49(4): p. 1325-33.
26. Brhane, Y., et al., Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. Cancer Epidemiol Biomarkers Prev, 2020.
27. Kong, X., et al., Overexpression of HIF-2alpha-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/beta-Catenin Signal Pathway. Cell Physiol Biochem, 2019. 52(3): p. 368-381.
28. Xiong, D.D., et al., The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA. Cell Physiol Biochem, 2018. 48(3): p. 905-918.
29. Qi, L., et al., lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis. Biomed Pharmacother, 2018. 103: p. 1507-1515.
30. Yang, X., et al., Silencing of the long non-coding RNA NEAT1 suppresses glioma stem-like properties through modulation of the miR-107/CDK6 pathway. Oncol Rep, 2017. 37(1): p. 555-562.
31. Liu, Y., et al., LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis. Anticancer Drugs, 2020.
32. Wei, X., et al., miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro. J Thorac Dis, 2020. 12(4): p. 1540-1551.
33. Fan, Y., et al., Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1. Biosci Rep, 2020. 40(1).
34. Wu, Z., et al., Downregulation of oncogenic gene TGFbetaR2 by miRNA-107 suppresses non-small cell lung cancer. Pathol Res Pract, 2020. 216(1): p. 152690.